It is also unclear whether any negative health effects may emerge with prolonged use, how pillbased options might influence adherence, and how regulators, insurers and health systems will adapt as usage grows
Batch identification for traceability
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
This number has probably increased even more since the poll was conducted, as the medications have become more accessible
Much like in the brain, inflammation is a common feature in several ocular pathologies, particularly those relating to the retina
Polyphenol-rich foods amplify Akkermansia Research shows that polyphenols, the antioxidant compounds found in colorful fruits and vegetables, specifically support Akkermansia muciniphila growth